Tissue Diagnostic Market Hits $ USD 6.4 Billion By 2022: Grand View Research, Inc. - PowerPoint PPT Presentation

Loading...

PPT – Tissue Diagnostic Market Hits $ USD 6.4 Billion By 2022: Grand View Research, Inc. PowerPoint presentation | free to download - id: 7413c5-Zjg4Y



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Tissue Diagnostic Market Hits $ USD 6.4 Billion By 2022: Grand View Research, Inc.

Description:

Tissue diagnostic, due to its ability to detect cancer at an early stage, is expected to witness significant growth over the forecast period. – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Tissue Diagnostic Market Hits $ USD 6.4 Billion By 2022: Grand View Research, Inc.


1
Global Tissue Diagnostic Market Expected To
Reach USD 6.4 Billion By 2022 Grand View
Research, Inc.
  • Grand View Research has announced the addition of
    "Global Tissue Diagnostic Market Analysis And
    Segment Forecasts To 2022" Market Research report
    to their Database

2
  • Global tissue diagnostic market (
    http//www.grandviewresearch.com/industry-analysis
    /tissue-diagnostics-market ) is expected to reach
    USD 6.4 billion by 2022, according to a new study
    by Grand View Research Inc. Tissue diagnostic,
    due to its ability to detect cancer at an early
    stage, is expected to witness significant growth
    over the forecast period. Increasing incidences
    of breast cancer, rising geriatric population
    base and the growing demand for personalized
    medicines are high impact rendering drivers of
    the tissue diagnostics market. Furthermore,
    improving healthcare infrastructure, increasing
    demand for safe and cost effective treatment and
    rising focus of major market players on emerging
    economies such as India and China are likely to
    propel market growth. Technological advancement
    occurring in the field of tissue diagnostics is
    expected to lead towards the availability of
    better option for healthcare professionals and
    the patients. Tissue diagnostic procedures
    encompass a broad array of technologies designed
    to revolutionize the cancer diagnosis process and
    provide apt molecular information. Tissue
    diagnostic detects the presence of malignant
    cells by performing microscopic study of the
    involved tissue. This investigation is considered
    to be vital for any type of cancer in order to
    decide the most effective treatment line.

3
  • Further key findings from the study suggest
  • Immunohistochemistry (IHC) is identified as the
    most lucrative sub segment of the tissue
    diagnostic market majorly owing to increasing
    incidences of cancer diagnostic
  • The tissue based breast cancer diagnostic
    segment accounted for the largest market share in
    2014. Rising alcohol consumption, lifestyle
    associated changes and growing geriatric
    population are some factors expected to drive
    segment growth over the forecast period.
  • North America accounted for over 40.0 of the
    tissue diagnostic market in 2014 on account of
    high usage rates of technologically advanced
    products. Rising patient awareness level and the
    presence of accessible healthcare infrastructure
    is also expected to contribute towards healthy
    regional market growth.
  • Asia Pacific is expected to witness the fastest
    growth over the forecast period. Rapid economic
    development and the consequent improvement of the
    healthcare infrastructure is expected to help
    manufacturers capitalize on the available
    opportunities in the form of unmet medical needs.
    Presence of sophisticated healthcare facilities
    in the developed markets of Japan and Australia
    is also expected to boost usage rates over the
    forecast period.
  • Key players of the tissue diagnostic market
    include Roche Diagnostics, Cell Signaling
    Technologies, Becton Dickinson Company, Agilent
    Technologies, Abbott Laboratories, GE Healthcare,
    Thermo Fisher Scientific, Johnson Johnson and
    Danaher Corporation.
  • For More http//www.grandviewresearch.com/industr
    y-analysis/tissue-diagnostics-market

4
  • Request free sample of this Report
    http//www.grandviewresearch.com/industry-analysis
    /tissue-diagnostics-market/request
  • For the purpose of this study, Grand View
    Research has segmented the global tissue
    diagnostic market on the basis of products,
    technology, application, end-use and region
  • Global Tissue Diagnostic Product Outlook
    (Revenue, USD Million, 2012 2022)
  • Instruments
  • Accessories
  • Global Tissue Diagnostic Technology Outlook
    (Revenue, USD Million, 2012 2022)
  • Immunohistochemistry (IHC)
  • In Situ Hybridization
  • Special Staining
  • Digital Pathology and Workflow
  • Global Tissue Diagnostic Application Outlook
    (Revenue, USD Million, 2012 2022)
  • Lymphoma
  • Breast Cancer
  • Gastric Cancer
  • Prostate Cancer
  • Non Small Cell Lung Cancer
  • Global Tissue Diagnostic End-use Outlook
    (Revenue, USD Million, 2012 2022)

5
Tissue Diagnostic Regional Outlook (Revenue, USD
Million, 2012 2022) North America U.S. Canada Re
st of North America Europe Germany France Spain R
est of Europe Asia Pacific Japan China India Rest
of Asia Pacific Latin America Brazil Mexico Rest
of Latin America Middle East and Africa (MEA)
South Africa Rest of Middle East and Africa  
6
  • Browse all reports at http//www.grandviewresearch
    .com/industry/clinical-diagnostics
  • About Grand View Research
  • Grand View Research, Inc. is a market research
    and consulting company that provides off-the-
    shelf, customized research reports and
    consulting services. To help clients make
    informed business decisions, we offer market
    intelligence studies, ensuring relevant and
    fact-based research across a range of industries,
    from technology to chemicals, materials and
    energy. With a deep-seated understanding of
    varied business environments, Grand View
    Research provides strategic objective insights.
  •  
  • Contact
  • Sherry James
  • Corporate Sales Specialist, USA
  • Grand View Research, Inc
  • Phone 1-415-349-0058
  • Toll Free 1-888-202-9519
  • Email sales_at_grandviewresearch.com
  • Website Grand View Research
  • Blog Site http//www.divog.org/
About PowerShow.com